Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East
23 Noviembre 2009 - 7:30AM
PR Newswire (US)
Company's Innovative Guidewire Improves Angioplasty Procedures
HAIFA, Israel, November 23 /PRNewswire-FirstCall/ -- Cardio
Vascular Medical Device Corp. (CVSL.OB),
http://www.cvslmedical.com/, a leading developer of advanced
cardiovascular surgery technology, today announced that the
company's Board of Directors has decided to initiate patent
applications in Europe, Canada and the Far East for its proprietary
next-generation "steerable guidewire" applicable for all
angioplasty (PCTA) procedures. Cardio Vascular Medical Device
already holds a US patent for the innovative guidewire. The company
has elected to apply for the additional patents in order to
penetrate a worldwide commercial marketplace for the life-saving
angioplasty procedure. Angioplasty is a common procedure that is
performed to widen narrowed or obstructed blood vessels. The
procedure is often performed in place of, or before a more invasive
and potentially life-threatening bypass surgery is needed.
Angioplasty that is performed before an artery is fully-blocked can
prevent the onset of heart attacks. More than seven million
angioplasties are performed worldwide each year. The potential
addressable market for angioplasty equipment exceeds $500 million.
According to the World Health Organization, some 7.2 million men
and women die as a result of cardiac heart disease. Heart disease
is the leading cause of death for both women and men in the United
States. "Filing these additional patent applications is the first
stage in aiding cardiologists in the process of saving lives across
the globe," stated Eli Gonen, CEO of Cardio Vascular Medical Device
Corp. "The ability to steer our guidewire during angioplasty
procedures using our patented flexi-tip enables more difficult
procedures to be completed with greater ease, and speeds overall
procedure time," Gonen added. "Due to these significant advantages,
Cardio Vascular Medical Device's guidewire has the opportunity to
become the guidewire of choice for surgeons throughout the world."
Forward-Looking Statements This letter contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended and Section 21E of the Securities Exchange Act
of 1934, as amended. All forward-looking statements are inherently
uncertain, based on current expectations and assumptions concerning
future events or future performance of Cardio Vascular Medical
Device Corp. and its technologies. In evaluating such statements,
prospective investors should review carefully various risks and
uncertainties identified in this release, as actual results may
differ materially from those indicated in the forward-looking
statements. Cardio Vascular Medical Device Corp. public filings may
be viewed at http://www.sec.gov/. Contact: Alex Traiman Media
Relations +1-646-863-9729 Asher Zwebner +972-54-464-6363
DATASOURCE: Cardio Vascular Medicine Device Corp. CONTACT: Contact:
Alex Traiman, Media Relations, +1-646-863-9729. Asher Zwebner,
+972-54-464-6363,
Copyright